Anwesha Pradhan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anwesha Pradhan has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Ajaya Kumar Moharana
Department of Urology, Tulane University School of Medicine, New Orleans, LA 70112, USA
1 shared publication - Lisa Goutami
Redox Biology & Proteomics Laboratory, Department of Zoology and Centre of Excellence for Environment and Public Health, Ravenshaw University, Cuttack 753003, India
1 shared publication - Luna Samanta
Redox Biology & proteomics Laboratory, Department of Zoology, Ravenshaw University, Cuttack, India
1 shared publication - Manesh Kumar Panner Selvam
Tulane University School of Medicine
1 shared publication - Soumya Ranjan Jena
Redox Biology & Proteomics Laboratory, Department of Zoology, Ravenshaw University, Cuttack 753003, Odisha, India
1 shared publication - Suresh C. Sikka
Department of Urology, Tulane University School of Medicine, New Orleans, LA 70112, USA
1 shared publication
Latest Publications
- Open Access
- 26 November 2025
- Published by MDPI AG in Antioxidants
- Vol. 14 (12) , 1410
Spermatozoa Proteins Involved in ROS Generation and Antioxidant Defense Are Differentially Acetylated in Idiopathic Infertility
Idiopathic male infertility (IMI), which accounts for nearly 50% of male infertility cases, remains a major clinical challenge due to the inability of standard semen analysis to reveal underlying molecular defects. Post-translational modifications such as lysine acetylation are increasingly recognized as key regulators of sperm function, affecting antioxidant defense, energy metabolism, and spermatogenesis. In this study, global acetyl-proteomic profiling of spermatozoa from idiopathic infertile patients (IIP) and fertile donors (FD) was performed using immunoprecipitation-based enrichment followed by high-resolution LC–MS/MS. Bioinformatics analyses, including STRING, Cytoscape, and Ingenuity Pathway Analysis (IPA), identified 718 differentially acetylated proteins (DAPs), with significant enrichment in pathways related to redox homeostasis, molecular transport, glycolysis, and mitochondrial metabolism. Hub proteins such as SOD1, PARK7, and PRKACA emerged as key regulators linking oxidative stress with defective motility and impaired sperm physiology. Western blot validation confirmed the downregulation of these hub proteins in IIP, supporting their role in redox imbalance and mitochondrial dysfunction. Our findings highlight dysregulated lysine acetylation as a defining molecular feature of IMI and suggest that targeting acetylation-associated pathways may provide novel diagnostic biomarkers and therapeutic strategies to improve sperm function and male reproductive outcomes.
- 26 November 2025
- Published by MDPI AG in Antioxidants
- Vol. 14 (12) , 1410
Open AccessSpermatozoa Proteins Involved in ROS Generation and Antioxidant Defense Are Differentially Acetylated in Idiopathic Infertility
Idiopathic male infertility (IMI), which accounts for nearly 50% of male infertility cases, remains a major clinical challenge due to the inability of standard semen analysis to reveal underlying molecular defects. Post-translational modifications such as lysine acetylation are increasingly recognized as key regulators of sperm function, affecting antioxidant defense, energy metabolism, and spermatogenesis. In this study, global acetyl-proteomic profiling of spermatozoa from idiopathic infertile patients (IIP) and fertile donors (FD) was performed using immunoprecipitation-based enrichment followed by high-resolution LC–MS/MS. Bioinformatics analyses, including STRING, Cytoscape, and Ingenuity Pathway Analysis (IPA), identified 718 differentially acetylated proteins (DAPs), with significant enrichment in pathways related to redox homeostasis, molecular transport, glycolysis, and mitochondrial metabolism. Hub proteins such as SOD1, PARK7, and PRKACA emerged as key regulators linking oxidative stress with defective motility and impaired sperm physiology. Western blot validation confirmed the downregulation of these hub proteins in IIP, supporting their role in redox imbalance and mitochondrial dysfunction. Our findings highlight dysregulated lysine acetylation as a defining molecular feature of IMI and suggest that targeting acetylation-associated pathways may provide novel diagnostic biomarkers and therapeutic strategies to improve sperm function and male reproductive outcomes.